Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
06 2019
Historique:
received: 16 05 2018
accepted: 10 04 2019
pubmed: 28 5 2019
medline: 10 7 2019
entrez: 29 5 2019
Statut: ppublish

Résumé

Group A Streptococcus (GAS; Streptococcus pyogenes) is a bacterial pathogen for which a commercial vaccine for humans is not available. Employing the advantages of high-throughput DNA sequencing technology to vaccine design, we have analyzed 2,083 globally sampled GAS genomes. The global GAS population structure reveals extensive genomic heterogeneity driven by homologous recombination and overlaid with high levels of accessory gene plasticity. We identified the existence of more than 290 clinically associated genomic phylogroups across 22 countries, highlighting challenges in designing vaccines of global utility. To determine vaccine candidate coverage, we investigated all of the previously described GAS candidate antigens for gene carriage and gene sequence heterogeneity. Only 15 of 28 vaccine antigen candidates were found to have both low naturally occurring sequence variation and high (>99%) coverage across this diverse GAS population. This technological platform for vaccine coverage determination is equally applicable to prospective GAS vaccine antigens identified in future studies.

Identifiants

pubmed: 31133745
doi: 10.1038/s41588-019-0417-8
pii: 10.1038/s41588-019-0417-8
pmc: PMC6650292
mid: EMS83447
doi:

Substances chimiques

Antigens, Bacterial 0
Streptococcal Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1035-1043

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 098051
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):E1768-76
pubmed: 24733896
Mol Biol Evol. 2007 Aug;24(8):1586-91
pubmed: 17483113
Clin Exp Vaccine Res. 2017 Jan;6(1):45-49
pubmed: 28168173
Emerg Infect Dis. 2016 Feb;22(2):224-32
pubmed: 26811918
BMC Genomics. 2017 Mar 10;18(1):224
pubmed: 28283023
Nat Genet. 2013 Jan;45(1):109-13
pubmed: 23222960
Bioinformatics. 2010 Mar 1;26(5):680-2
pubmed: 20053844
Mol Biol Evol. 2017 May 1;34(5):1167-1182
pubmed: 28199698
J Clin Microbiol. 2014 Jun;52(6):1871-6
pubmed: 24648555
Vaccine. 2011 Oct 26;29(46):8175-8
pubmed: 21920403
Antimicrob Agents Chemother. 2008 Mar;52(3):1140-3
pubmed: 18180360
PeerJ. 2017 Apr 27;5:e3226
pubmed: 28462035
J Mol Med (Berl). 2012 Oct;90(10):1197-207
pubmed: 22527883
ISME J. 2009 Feb;3(2):199-208
pubmed: 18830278
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Genome Biol. 2018 Oct 4;19(1):153
pubmed: 30286803
Mol Cell Proteomics. 2012 Jun;11(6):M111.015693
pubmed: 22286755
mBio. 2014 Apr 22;5(2):e01074
pubmed: 24757216
Nat Genet. 2015 Jan;47(1):84-7
pubmed: 25401300
N Engl J Med. 2017 Aug 24;377(8):713-722
pubmed: 28834488
J Clin Microbiol. 2000 Mar;38(3):1008-15
pubmed: 10698988
J Infect Dis. 2003 May 15;187(10):1598-608
pubmed: 12721940
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
PLoS Genet. 2017 Jun 26;13(6):e1006855
pubmed: 28650958
J Mol Biol. 2014 Feb 20;426(4):785-92
pubmed: 24316049
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11833-8
pubmed: 15282372
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Environ Microbiol. 2007 Mar;9(3):643-56
pubmed: 17298365
Microb Genom. 2016 Aug 25;2(8):e000083
pubmed: 28348874
Infect Immun. 2001 Apr;69(4):2416-27
pubmed: 11254602
Genome Res. 2019 Feb;29(2):304-316
pubmed: 30679308
JAMA. 2004 Aug 11;292(6):709-15
pubmed: 15304468
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Bioinformatics. 2018 Dec 15;34(24):4310-4312
pubmed: 30535304
J Mol Biol. 2014 Jul 15;426(14):2692-701
pubmed: 24810707
J Infect Dis. 2005 Sep 1;192(5):771-82
pubmed: 16088826
PLoS Genet. 2019 Apr 15;15(4):e1008114
pubmed: 30986243
Clin Dev Immunol. 2006 Jun-Dec;13(2-4):125-32
pubmed: 17162355
Infect Immun. 1996 Jul;64(7):2548-55
pubmed: 8698478
J Bacteriol. 2005 Sep;187(17):6223-30
pubmed: 16109964
Clin Infect Dis. 2005 Oct 15;41(8):1114-22
pubmed: 16163629
Nature. 2017 Apr 20;544(7650):357-361
pubmed: 28273061
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
Sci Rep. 2016 Nov 08;6:36644
pubmed: 27821851
J Clin Microbiol. 2005 Aug;43(8):4178-82
pubmed: 16081970
Infect Immun. 1997 Jun;65(6):2080-7
pubmed: 9169735
EBioMedicine. 2018 Feb;28:128-135
pubmed: 29342444
Curr Top Microbiol Immunol. 2013;368:207-42
pubmed: 23250780
PLoS One. 2015 Jul 10;10(7):e0130955
pubmed: 26161978
mBio. 2015 Jul 14;6(4):e00622
pubmed: 26173696
Nucleic Acids Res. 2016 Jul 8;44(W1):W16-21
pubmed: 27141966
Clin Microbiol Rev. 2014 Apr;27(2):264-301
pubmed: 24696436
J Clin Microbiol. 1996 Apr;34(4):953-8
pubmed: 8815115
Lancet Infect Dis. 2009 Oct;9(10):611-6
pubmed: 19778763
J Immunol. 2016 Apr 15;196(8):3364-74
pubmed: 26969753
mBio. 2018 Jan 30;9(1):
pubmed: 29382733
Nat Med. 2000 Apr;6(4):455-9
pubmed: 10742155
Cell Host Microbe. 2014 Jun 11;15(6):729-740
pubmed: 24922575
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
J Infect Dis. 2014 Oct 15;210(8):1325-38
pubmed: 24799598
Nat Commun. 2016 Sep 16;7:12797
pubmed: 27633831
mBio. 2017 Sep 19;8(5):
pubmed: 28928212
Nat Ecol Evol. 2017 Dec;1(12):1950-1960
pubmed: 29038424
J Infect Dis. 2006 Jan 1;193(1):129-35
pubmed: 16323141
Nucleic Acids Res. 2012 Jan;40(1):e6
pubmed: 22064866
Int J Med Microbiol. 2014 May;304(3-4):370-8
pubmed: 24444719
Future Microbiol. 2009 Sep;4(7):819-35
pubmed: 19722837
Microb Pathog. 1994 Aug;17(2):111-20
pubmed: 7861955
Microb Genom. 2016 Nov 30;2(11):e000093
pubmed: 28348833
Nat Genet. 2014 Mar;46(3):305-309
pubmed: 24509479
Nat Genet. 2013 Jun;45(6):656-63
pubmed: 23644493
PLoS One. 2016 Dec 15;11(12):e0168177
pubmed: 27977735
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
mBio. 2016 Sep 27;7(5):
pubmed: 27677790
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
J Mol Biol. 2009 Feb 27;386(3):754-72
pubmed: 19152799

Auteurs

Mark R Davies (MR)

Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia. mark.davies1@unimelb.edu.au.
The Wellcome Trust Sanger Institute, Hinxton, UK. mark.davies1@unimelb.edu.au.
School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia. mark.davies1@unimelb.edu.au.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia. mark.davies1@unimelb.edu.au.

Liam McIntyre (L)

Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Ankur Mutreja (A)

The Wellcome Trust Sanger Institute, Hinxton, UK.
GSK Vaccines Institute for Global Health, Siena, Italy.

Jake A Lacey (JA)

Doherty Department, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

John A Lees (JA)

Department of Microbiology, New York University School of Medicine, New York, NY, USA.

Rebecca J Towers (RJ)

Menzies School of Health Research, Darwin, Northern Territory, Australia.

Sebastián Duchêne (S)

Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.

Pierre R Smeesters (PR)

Molecular Bacteriology Laboratory, Université Libre de Bruxelles, Brussels, Belgium.
Department of Pediatrics, Queen Fabiola Childrens University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.

Hannah R Frost (HR)

Molecular Bacteriology Laboratory, Université Libre de Bruxelles, Brussels, Belgium.
Department of Pediatrics, Queen Fabiola Childrens University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.

David J Price (DJ)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Victorian Infectious Diseases Reference Laboratory Epidemiology Unit, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Matthew T G Holden (MTG)

The Wellcome Trust Sanger Institute, Hinxton, UK.
School of Medicine, University of St Andrews, St Andrews, UK.

Sophia David (S)

The Wellcome Trust Sanger Institute, Hinxton, UK.

Philip M Giffard (PM)

Menzies School of Health Research, Darwin, Northern Territory, Australia.

Kate A Worthing (KA)

Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Anna C Seale (AC)

Wellcome Trust Research Centre, Kilifi, Kenya.

James A Berkley (JA)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Simon R Harris (SR)

The Wellcome Trust Sanger Institute, Hinxton, UK.

Tania Rivera-Hernandez (T)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.

Olga Berking (O)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.

Amanda J Cork (AJ)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.

Rosângela S L A Torres (RSLA)

Laboratory of Bacteriology, Epidemiology Laboratory and Disease Control Division, Laboratório Central do Estado do Paraná, Curitiba, Brazil.
Department of Medicine, Universidade Positivo, Curitiba, Brazil.

Trevor Lithgow (T)

Infection and Immunity Program, Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, Victoria, Australia.

Richard A Strugnell (RA)

Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Rene Bergmann (R)

Helmholtz Centre for Infection Research, Braunschweig, Germany.

Patric Nitsche-Schmitz (P)

Helmholtz Centre for Infection Research, Braunschweig, Germany.

Gusharan S Chhatwal (GS)

Helmholtz Centre for Infection Research, Braunschweig, Germany.

Stephen D Bentley (SD)

The Wellcome Trust Sanger Institute, Hinxton, UK.

John D Fraser (JD)

Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Nicole J Moreland (NJ)

Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Jonathan R Carapetis (JR)

Telethon Kids Institute, University of Western Australia and Perth Children's Hospital, Perth, Western Australia, Australia.

Andrew C Steer (AC)

Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.

Julian Parkhill (J)

The Wellcome Trust Sanger Institute, Hinxton, UK.

Allan Saul (A)

GSK Vaccines Institute for Global Health, Siena, Italy.

Deborah A Williamson (DA)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Bart J Currie (BJ)

Menzies School of Health Research, Darwin, Northern Territory, Australia.

Steven Y C Tong (SYC)

Doherty Department, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Menzies School of Health Research, Darwin, Northern Territory, Australia.
Victorian Infectious Disease Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Gordon Dougan (G)

The Wellcome Trust Sanger Institute, Hinxton, UK.
Department of Medicine, University of Cambridge, Cambridge, UK.

Mark J Walker (MJ)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia. mark.walker@uq.edu.au.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia. mark.walker@uq.edu.au.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH